Cargando…
CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice
In addition to motor dysfunction, patients with Parkinson’s disease (PD) are often affected by neuropsychiatric disorders, such as anxiety and depression. In animal models, activation of the endocannabinoid (eCB) system produces anxiolytic and antidepressant-like behavioral effects. CB2 agonists hav...
Autores principales: | Liu, Xiaojie, Yu, Hao, Chen, Bixuan, Friedman, Vladislav, Mu, Lianwei, Kelly, Thomas J., Ruiz-Pérez, Gonzalo, Zhao, Li, Bai, Xiaowen, Hillard, Cecilia J., Liu, Qing-song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329798/ https://www.ncbi.nlm.nih.gov/pubmed/35892676 http://dx.doi.org/10.3390/biomedicines10081776 |
Ejemplares similares
-
The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson’s Disease
por: Yu, Hao, et al.
Publicado: (2021) -
Cannabinoid receptor subtype 2 (CB(2)R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells
por: Huang, Zebing, et al.
Publicado: (2016) -
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats
por: Song, Lu, et al.
Publicado: (2014) -
Epac2 in midbrain dopamine neurons contributes to cocaine reinforcement via enhancement of dopamine release
por: Liu, Xiaojie, et al.
Publicado: (2022) -
Involvement of dynorphin in anxiogenic effects of estrogen
por: Kastenberger, Iris, et al.
Publicado: (2009)